WCN24-1323 TO DETERMINE THE EFFICACY OF LACTOFERRIN IN IMPROVING HEMOGLOBIN LEVELS IN CHRONIC KIDNEY DISEASE PATIENTS WITH IRON DEFICIENCY ANEMIA

Nutritional anemia i.e. iron deficiency anemia and CKD are prevalent in developing countries. CKD patient population has poor tolerance to oral iron as compared to healthy individuals and thus inadequate response to iron. This leads to complications like gastrointestinal side effects. Studies have shown that adding Lactoferrin to iron treatment improves iron deficiency anemia in pregnant women and patients with malignancy. Data on efficacy of this drug in the treatment of anemia in CKD is scarce.